174 related articles for article (PubMed ID: 20160274)
21. Breast cancer recurrence risk reduction beliefs in breast cancer survivors: prevalence and relation to behavior.
Burris JL; Jacobsen PB; Loftus LS; Andrykowski MA
Psychooncology; 2012 Apr; 21(4):427-35. PubMed ID: 21312312
[TBL] [Abstract][Full Text] [Related]
22. Perception of recurrent risk versus objective measured risk of ischemic stroke in first-ever stroke patients from a rural area in China: A cross-sectional study.
Ren H; Guo YF; Zhang ZX; Lin BL; Mei YX; Wang WN; Luan WY; Zhang XY; Liang LL; Xue LH
Patient Educ Couns; 2023 Feb; 107():107586. PubMed ID: 36495680
[TBL] [Abstract][Full Text] [Related]
23. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
[TBL] [Abstract][Full Text] [Related]
24. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.
Silverstein MJ; Lagios MD; Martino S; Lewinsky BS; Craig PH; Beron PJ; Gamagami P; Waisman JR
J Clin Oncol; 1998 Apr; 16(4):1367-73. PubMed ID: 9552039
[TBL] [Abstract][Full Text] [Related]
25. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
26. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R
Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041
[TBL] [Abstract][Full Text] [Related]
27. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
[TBL] [Abstract][Full Text] [Related]
28. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Boyages J; Delaney G; Taylor R
Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
[TBL] [Abstract][Full Text] [Related]
29. Predictors and patterns of fear of cancer recurrence in breast cancer survivors.
McGinty HL; Small BJ; Laronga C; Jacobsen PB
Health Psychol; 2016 Jan; 35(1):1-9. PubMed ID: 26030308
[TBL] [Abstract][Full Text] [Related]
30. Investigating fear of cancer recurrence among female breast cancer survivors and their spouses in southwest China: a cross-sectional study.
Tao L; Ma X; Yang Y; Hu X; Fu L; Li J
BMJ Open; 2024 Feb; 14(2):e077964. PubMed ID: 38331853
[TBL] [Abstract][Full Text] [Related]
31. Through her eyes.
Schnur JB; Goldsmith RE
J Clin Oncol; 2011 Oct; 29(30):4054-6. PubMed ID: 21768455
[No Abstract] [Full Text] [Related]
32. Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ?
Chaudhary LN; Jawa Z; Hanif A; Szabo A; Kamaraju S; Cheng YC; Chitambar CR
WMJ; 2018 Jun; 117(2):62-67. PubMed ID: 30048574
[TBL] [Abstract][Full Text] [Related]
33. Revision of the fear of cancer recurrence cognitive and emotional model by Lee-Jones et al with women with breast cancer.
Maheu C; Hébert M; Louli J; Yao TR; Lambert S; Cooke A; Black A; Kyriacou J
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1172. PubMed ID: 32721129
[TBL] [Abstract][Full Text] [Related]
34. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
[TBL] [Abstract][Full Text] [Related]
35. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
37. The voice of the breast cancer patient--a lonely cry in the wilderness.
Thornton H
Eur J Cancer; 1997 May; 33(6):825-8. PubMed ID: 9291800
[No Abstract] [Full Text] [Related]
38. Influential factors in Black and White breast cancer survivors' beliefs about breast cancer.
Edmonds MC; Dahman B; McGuire K; Sheppard VB
Psychooncology; 2022 Feb; 31(2):271-281. PubMed ID: 34590395
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Study of Weight Gain in Women Diagnosed with Early-Stage Invasive Breast Cancer, Ductal Carcinoma
Ekenga CC; Wang X; Pérez M; Schootman M; Jeffe DB
J Womens Health (Larchmt); 2020 Apr; 29(4):524-533. PubMed ID: 31460829
[No Abstract] [Full Text] [Related]
40. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
